Teladoc Health (TDOC) under pressure after Q4 earnings, JPMorgan analyst Lisa Gill reaffirms neutral rating, price target $11. Revenue estimate of $617.5 million for Q1.
Telemedicine specialist Teladoc Health (TDOC 1.53%) has been a terrible investment over the past three years. Once the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results